CA52386/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2001	2
2002	8
2003	5
2004	1
2006	2
2012	1
2024	0

1

High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.

Talbot SM, Rankin C, Taub RN, Balcerzak SP Jr, Bhoopalam N, Chapman RA, Baker LH, Middleman EL, Antman KH. Talbot SM, et al. Cancer. 2003 Jul 15;98(2):331-6. doi: 10.1002/cncr.11512. Cancer. 2003. PMID: 12872353 Free article. Clinical Trial.

2

Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504.

Gandara DR, Chansky K, Albain KS, Leigh BR, Gaspar LE, Lara PN Jr, Burris H, Gumerlock P, Kuebler JP, Bearden JD 3rd, Crowley J, Livingston R; Southwest Oncology Group. Gandara DR, et al. J Clin Oncol. 2003 May 15;21(10):2004-10. doi: 10.1200/JCO.2003.04.197. J Clin Oncol. 2003. PMID: 12743155 Clinical Trial.

3

Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome.

Sosman JA, Unger JM, Liu PY, Flaherty LE, Park MS, Kempf RA, Thompson JA, Terasaki PI, Sondak VK; Southwest Oncology Group. Sosman JA, et al. J Clin Oncol. 2002 Apr 15;20(8):2067-75. doi: 10.1200/JCO.2002.08.072. J Clin Oncol. 2002. PMID: 11956267 Clinical Trial.

4

Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients.

Berenson JR, Crowley JJ, Grogan TM, Zangmeister J, Briggs AD, Mills GM, Barlogie B, Salmon SE. Berenson JR, et al. Blood. 2002 May 1;99(9):3163-8. doi: 10.1182/blood.v99.9.3163. Blood. 2002. PMID: 11964279 Free article. Clinical Trial.

5

Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).

Gandara DR, Chansky K, Albain KS, Gaspar LE, Lara PN Jr, Kelly K, Crowley J, Livingston R. Gandara DR, et al. Clin Lung Cancer. 2006 Sep;8(2):116-21. doi: 10.3816/CLC.2006.n.039. Clin Lung Cancer. 2006. PMID: 17026812 Clinical Trial.

6

Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial.

Rothenberg ML, Liu PY, Braly PS, Wilczynski SP, Hannigan EV, Wadler S, Stuart G, Jiang C, Markman M, Alberts DS. Rothenberg ML, et al. J Clin Oncol. 2003 Apr 1;21(7):1313-9. doi: 10.1200/JCO.2003.07.031. J Clin Oncol. 2003. PMID: 12663720 Clinical Trial.

7

Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study.

Rothenberg ML, Benedetti JK, Macdonald JS, Seay TE, Neubauer MA, George CS, Tanaka MS Jr, Giguere JK, Pruitt BT, Abbruzzese JL. Rothenberg ML, et al. Ann Oncol. 2002 Oct;13(10):1576-82. doi: 10.1093/annonc/mdf274. Ann Oncol. 2002. PMID: 12377645 Free article. Clinical Trial.

8

A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group study.

Whitehead RP, Unger JM, Flaherty LE, Kraut EH, Mills GM, Klein CE, Chapman RA, Doolittle GC, Hammond N, Sondak VK; Southwest Oncology Group. Whitehead RP, et al. Invest New Drugs. 2002 Feb;20(1):105-11. doi: 10.1023/a:1014484821460. Invest New Drugs. 2002. PMID: 12003185 Free article. Clinical Trial.

9

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.

Anderson JE, Kopecky KJ, Willman CL, Head D, O'Donnell MR, Luthardt FW, Norwood TH, Chen IM, Balcerzak SP, Johnson DB, Appelbaum FR. Anderson JE, et al. Blood. 2002 Dec 1;100(12):3869-76. doi: 10.1182/blood-2001-12-0354. Epub 2002 Aug 1. Blood. 2002. PMID: 12393614 Free article. Clinical Trial.

10

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).

Blayney DW, LeBlanc ML, Grogan T, Gaynor ER, Chapman RA, Spiridonidis CH, Taylor SA, Bearman SI, Miller TP, Fisher RI; Southwest Oncology Group. Blayney DW, et al. J Clin Oncol. 2003 Jul 1;21(13):2466-73. doi: 10.1200/JCO.2003.06.137. J Clin Oncol. 2003. PMID: 12829664 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year